PMID: 11932086Apr 5, 2002Paper

Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report

The Journal of Emergency Medicine
Travis Minish, Anthony Herd

Abstract

We present a case report describing an interaction between topical timolol maleate, verapamil, and flecainide resulting in symptomatic bradycardia. Adverse drug interactions, including topical medications, are relevant in the differential diagnosis of many presenting complaints.

References

Aug 2, 1979·The New England Journal of Medicine·C J Diskin
Oct 1, 1979·American Journal of Ophthalmology·C D McMahonJ Hetherington
Jan 17, 1987·British Medical Journal·S D Pringle, C J MacEwen
Dec 1, 1985·Annals of Internal Medicine·Y DinaiH Halkin
Jan 1, 1981·Pharmacology & Therapeutics·D N MiddlemissD T Greenwood
Aug 27, 1981·The New England Journal of Medicine·J Koch-Weser, W H Frishman
Sep 15, 1984·British Medical Journal·S J HutchisonS G McAlpine
Apr 1, 1981·Archives of Ophthalmology·E M Van Buskirk, F T Fraunfelder

❮ Previous
Next ❯

Citations

Sep 9, 2015·Case Reports in Critical Care·Muhammad Asim RanaWaleed Tharwat Aletreby
Oct 21, 2016·Expert Opinion on Drug Safety·Jukka Mäenpää, Olavi Pelkonen
Feb 1, 2010·Journal of Pharmacy Practice·Weeranuj YamreudeewongPatricia D Stepp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Optometry : Journal of the American Optometric Association
Timothy Hug, Scott Olitsky
Australian Journal of Ophthalmology
F W Fraunfelder, S M Meyer
© 2022 Meta ULC. All rights reserved